Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | DHODH | Q02127 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.41 |
| ▸ | DHPS | P49366 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516983 | 0.83 | HDAC3 (0.56) | CYP2C9SMN1; SMN2RAB9ANPC1LMNA | |
| SCHEMBL9994871 | 0.81 | CYP2C9 (0.43) | CYP2C9SMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL8460893 | 0.77 | CYP2C9 (0.60) | CYP2C9RAB9ANPC1ALDH1A1HTT | |
| SCHEMBL517354 | 0.72 | MAOA (0.56) | RAB9ANPC1HDAC3HDAC8HDAC6 | |
| SCHEMBL517322 | 0.70 | NPC1 (0.59) | CYP2C9SMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL516878 | 0.69 | HPGD (0.50) | SMN1; SMN2RAB9ANPC1ALDH1A1HTT | |
| SCHEMBL10762782 | 0.69 | CYP2C9 (0.50) | CYP2C9RAB9ANPC1ALDH1A1HTT | |
| SCHEMBL7223016 | 0.69 | CYP2C9 (0.50) | CYP2C9SMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL517294 | 0.69 | RAB9A (0.43) | SMN1; SMN2RAB9ANPC1MAPTHPGD | |
| SCHEMBL517016 | 0.68 | L3MBTL1 (0.57) | SMN1; SMN2RAB9ANPC1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9023921-B2 | Method for inhibiting crystal growth rate of amide compound and method for producing molded article of polyolefin-based resin | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2015-05-05 | — | — | US | disclosed |
| US-8592071-B2 | Laminated porous film and separator for battery | MITSUBISHI PLASTICS, INC. (JP) | 2013-11-26 | — | — | US | disclosed |
| EP-2431415-A1 | METHOD FOR CONTROLLING CRYSTAL GROWTH RATE OF AMIDE COMPOUND AND METHOD FOR PRODUCING MOLDED ARTICLE OF POLYOLEFIN-BASED RESIN | New Japan Chemical Co., Ltd. (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20120035304-A1 | METHOD FOR INHIBITING CRYSTAL GROWTH RATE OF AMIDE COMPOUND AND METHOD FOR PRODUCING MOLDED ARTICLE OF POLYOLEFIN-BASED RESIN | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20110212358-A1 | LAMINATED POROUS FILM AND SEPARATOR FOR BATTERY | MITSUBISHI PLASTICS, INC. (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035304-A1 | METHOD FOR INHIBITING CRYSTAL GROWTH RATE OF AMIDE COMPOUND AND METHOD FOR PRODUCING MOLDED ARTICLE OF POLYOLEFIN-BASED RESIN | MNAT1, RFT1, RTF1 | CYP2C9 3051/4885SMN1; SMN2 3244/4885RAB9A 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.